<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1101221582
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2013
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AUGMENTIN ES SUSPENSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        600,42.9
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        32.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXOWELLCOME" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXOWELLCOME
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1182]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Augmentin ES is an antibiotic which contains two active ingredients. One of these is a penicillin called amoxicillin (present as amoxicillin trihydrate) and the other is clavulanic acid (present as potassium clavulanate).</p><p>&nbsp;</p><p>AUGMENTIN ES is usually prescribed for children aged 3 months and older.</p><p>Augmentin ES is used to treat children with infections caused by bacteria.</p><p>Ask your doctor or pharmacist if you would like any further explanation about these uses.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not give Augmentin ES suspension if:</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your child is allergic to amoxicillin or beta-lactam antibiotics (such as penicillins and cephalosporins) or any of the other ingredients of AUGMENTIN ES. If they have had an allergic reaction (such as a rash) when taking an antibiotic, you should talk to your doctor before you give AUGMENTIN ES.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your child has ever had jaundice (yellowing of the skin and/or eyes) or liver disease while taking AUGMENTIN ES.</p><p><strong>Take special care and get advice from your doctor if:</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your child develops signs of an allergic reaction (such as a skin rash or repetitive vomiting within 1 to 4 hours of AUGMENTIN ES administration) while taking AUGMENTIN ES. Do not give any more suspension and tell the doctor at once.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your child has glandular fever (mononucleosis) and they are prescribed AUGMENTIN ES. Please tell the doctor before you give the medicine.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your child has liver or kidney problems. The dosage may need to be reduced or they may need to be given a different medicine.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your child suffers from a condition called phenylketonuria (PKU).&nbsp; This is because AUGMENTIN ES contains aspartame.</p><p>&nbsp;</p><p><strong>Giving other medicines, herbal or dietary supplements </strong></p><p>Please tell your doctor or pharmacist if you are giving or have recently given your child any other medicines. This includes medicines that you buy without a prescription and herbal medicines for your child. This is because Augmentin can affect the way some medicines work. Also some other medicines can affect the way Augmentin works.</p><p>&nbsp;</p><p>It is particularly important that the doctor knows if your child is taking the following medicines:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allopurinol.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Probenecid.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anticoagulants (used to prevent blood clots) such as warfarin.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mycophenolate mofetil.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methotrexate (used to treat conditions such as cancer and severe psoriasis).</p><p>&nbsp;</p><p>If you are not sure if any of the above applies to your child, talk to your doctor or pharmacist before giving Augmentin ES suspension.</p><p><strong>Pregnancy and breast-feeding</strong></p><p><strong><em>This dosage form is intended for children. The following instructions are general for all Augmentin forms:</em></strong></p><p>As with all medicines, do not use Augmentin if the patient is pregnant, especially in the first 3 months, unless considered essential by your doctor.</p><p>Talk to your doctor or pharmacist before taking Augmentin if you are or might be pregnant.</p><p>Augmentin is considered having no problem to be taken with lactation except for the risk of developing allergy. Ask your doctor for advice before taking any medicine.</p><p><strong>&nbsp;</strong></p><p><strong>Effects on ability to drive and use machines.</strong></p><p>Augmentin has no reported effects on the ability to drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You must follow the doctor&#39;s advice and use the medicine as instructed.&nbsp; The doctor will decide how much medicine you need to give each day, and how many days you should give it for.</p><p>If there is anything you do not understand please ask your doctor or pharmacist.</p><p>It is better to give AUGMENTIN ES at the same time as a meal, but AUGMENTIN ES still works if it is given without food.</p><p>Instructions on how to prepare AUGMENTIN ES suspension are provided at the end of this leaflet.</p><p>Shake the bottle well before taking each dose.</p><p>A dosing device may be supplied with the pack, which you can use to measure the dose accurately.</p><p>Make sure the whole dose is swallowed every time.</p><p>If you are giving AUGMENTIN ES to a child up to 2 years old, the dose can be diluted to half-strength using water immediately before you give it. Do not store diluted medicine.</p><p><strong>&nbsp;</strong></p><p><strong>ONCE YOU HAVE STARTED GIVING AUGMENTIN ES</strong></p><p>Keep giving the medicine until the complete course has been finished.&nbsp; Do not stop when your child feels better.</p><p><strong>&nbsp;</strong></p><p><strong>If your child has taken more Augmentin ES than they should:</strong></p><p>Give plenty of water to drink and contact a doctor. Show the doctor the pack of AUGMENTIN ES.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to give a dose of Augmentin ES: </strong></p><p>Give it as soon as you remember, then carry on as before, but do not give two doses within an hour of each other.</p><p>&nbsp;</p><p>If you have any further question on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Augmentin ES<strong> </strong>can cause side effects, but not everybody gets them.</p><p>Look out for important symptoms<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-fareast-font-family:"MS Mincho";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-fareast-language:JA;mso-bidi-font-weight:normal;mso-bidi-font-style:
italic'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_e1b458aa-bff2-4e3c-be38-946948b21236 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-fareast-font-family:"MS Mincho";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-fareast-language:JA;mso-bidi-font-weight:normal;mso-bidi-font-style:
italic'><span style='mso-element:field-end'></span></span><![endif]--></p><p>Severe allergic reactions</p><p>These are very rare in people taking Augmentin ES. Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Raised, itchy rash (hives)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of blood vessels (vasculitis) which may be visible as red or purple raised spots on the skin, but can affect other parts of the body</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever, joint pain, swollen glands in the neck, armpit or groin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling, sometimes of the face or mouth (angioedema), which may cause difficulty in swallowing or breathing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Collapse.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain which can be a sign of a potentially serious allergic reaction called <em>Kounis syndrome</em>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Repetitive vomiting (1 to 4 hours after AUGMENTIN ES administration), stomach pain, abnormal drowsiness, diarrhoea and low blood pressure which can be a sign of a serious allergic reaction called drug-induced enterocolitis syndrome.</p><p>&egrave; <strong>Get medical help immediately</strong> if your child gets any of these symptoms. <strong>Stop giving your child</strong><strong> <em>Augmentin ES</em></strong>.</p><p>Serious skin reactions</p><p>These are rare in people taking <em>Augmentin ES</em>. Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; erythema multiforme).</p><p>These are very rare in people taking <em>Augmentin ES</em>. Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes, and genitals (<em>Stevens-Johnson syndrome</em>), and a more severe form, causing blisters and peeling skin on much of the body surface (<em>toxic epidermal necrolysis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A widespread, red, skin rash with small blisters containing pus (<em>exanthemous pustulosis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A red, itchy, scaly rash with blisters and bumps under the skin (<em>bullous exfoliative dermatitis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flu-like symptoms with a rash, fever, swollen glands, and abnormal blood test results (including white blood cells (<em>eosinophilia</em>) and liver enzymes) (<em>Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)</em>).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A red rash commonly seen on both sides of buttocks, upper inner thighs, armpits, neck (Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE)).</p><p>&nbsp;</p><p>&egrave; <strong>Get medical help immediately</strong> if your child gets any of these symptoms. <strong>Stop giving your child</strong><strong> <em>Augmentin ES</em></strong>.</p><p>Serious liver problems</p><p>On rare occasions, medicines like Augmentin ES can cause liver problems, causing yellowing of the skin and/or whites of the eyes.</p><p>&egrave; Tell your doctor as soon as possible if your child gets any of these symptoms.</p><p>Severe diarrhoea (<em>Pseudomembranous colitis</em>)</p><p>On rare occasions, medicines like Augmentin ES<strong> </strong>can cause inflammation of the colon (large intestine), causing diarrhoea, usually with blood and mucus, stomach pain and fever.</p><p>&egrave; Tell your doctor as soon as possible if your child gets any of these symptoms.</p><p>Common side effects<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-fareast-font-family:"MS Mincho";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-fareast-language:JA;mso-bidi-font-weight:normal;mso-bidi-font-style:
italic'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_feada77d-3886-468c-ab17-f14c5f3b9339 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-fareast-font-family:"MS Mincho";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-fareast-language:JA;mso-bidi-font-weight:normal;mso-bidi-font-style:
italic'><span style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 10</strong> people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thrush (fungal infection caused by <em>Candida</em> in the vagina, mouth or skin folds)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (<em>nausea</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea</p><p>Uncommon side effects<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US;mso-bidi-font-weight:normal;mso-bidi-font-style:italic'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_c6cec327-9a8c-46ad-a3b5-70323becc6b8 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US;mso-bidi-font-weight:normal;mso-bidi-font-style:italic'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 100</strong> people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indigestion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itchy, bumpy rash (<em>hives</em>)</p><p>Uncommon side effects that may show up in blood tests are:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in some substances (enzymes) produced by the liver</p><p>Rare side effects<!--[if supportFields]><span style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:EN-US;
mso-bidi-font-weight:normal;mso-bidi-font-style:italic'><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_56d681cd-d1e0-483c-a6b7-e1c4df0cc3f1
\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US;mso-bidi-font-weight:normal;mso-bidi-font-style:italic'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 1,000</strong> people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; <em>erythema multiforme</em>) (See &lsquo;<em>serious skin reactions</em>&rsquo; earlier in Section 4)</p><p>Rare side effects that may show up in blood tests are:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in the number of white blood cells (<em>leucopenia, </em>including<em> neutropenia</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in the number of cells that help blood to clot (<em>thrombocytopenia</em>)</p><p>Very rare side effects<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US;mso-bidi-font-weight:normal;mso-bidi-font-style:italic'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_04ed9ab4-5e63-4940-b104-6bcf867c477a \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US;mso-bidi-font-weight:normal;mso-bidi-font-style:italic'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 10,000</strong> people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe allergic reactions (See also &lsquo;<strong><em>severe allergic reactions</em></strong>&rsquo; earlier in Section&nbsp;4)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serious skin reactions (See also &lsquo;<strong><em>serious skin reactions</em></strong>&rsquo; earlier in Section&nbsp;4)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the liver (hepatitis) (See also &lsquo;<strong><em>serious liver problems</em></strong>&rsquo; earlier in Section&nbsp;4)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yellowing of the whites of the eyes or skin (jaundice) (See also &lsquo;<strong><em>serious liver problems</em></strong>&rsquo; earlier in Section&nbsp;4)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the large intestines (See also &lsquo;<strong><em>severe diarrhoea</em></strong>&rsquo; earlier in Section&nbsp;4)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the kidney (<em>nephritis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An increase in the time blood takes to clot</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Being unusually active (<em>hyperactivity</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fits (<em>seizures</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Black tongue which looks hairy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the protective membrane surrounding the brain (<em>aseptic meningitis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stained teeth that can usually be removed by brushing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash with blisters arranged in a circle with central crusting or like a string of pearls (linear IgA disease)</p><p>Very rare side effects that may show up in blood or urine tests are:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe decrease in the number of white blood cells (<em>agranulocytosis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Red blood cells destroyed too quickly (<em>haemolytic anaemia</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Crystals in urine</p><p>&egrave;&nbsp; <strong>Tell your doctor or pharmacist</strong> if any of the side effects listed becomes <strong>severe or troublesome for your child</strong>, or if your child has any side effects not listed in this leaflet</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Keep out of the reach and sight of children.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Augmentin ES suspension after the expiry date which is stated on the pack after &lsquo;Exp&rsquo;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store Augmentin dry powder in tightly closed containers in a dry place at below 30&deg;C in the original packaging to protect from moisture.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reconstituted suspension should be stored in a refrigerator (2-8&deg; C) and used within ten days, do not freeze.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your doctor tells you to stop giving Augmentin ES suspension, it is important to return any remnants which are left over to your pharmacist.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Augmentin ES 600 suspension contains</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Active ingredients:</p><p><em>AUGMENTIN ES 600 suspension </em>when prepared contains 600 mg amoxicillin (as amoxicillin trihydrate) and 42.9 mg clavulanic acid (as potassium clavulanate) per 5 ml. a 14:1 ratio.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other non active ingredients:</p><p>&sect;&nbsp; <em>Orange flavour</em></p><p>Colloidal silicon dioxide, orange flavour, golden syrup flavour, xanthan gum, aspartame, hydroxypropylmethylcellulose and silicon dioxide.</p><p>&sect;&nbsp; <em>Strawberry&nbsp; flavour</em></p><p>Colloidal silicon dioxide, sodium carboxymethylcellulose-12, strawberry cream flavour, xanthan gum, aspartame, and silicon dioxide.</p><p><strong>Excipients requiring special warnings</strong></p><p>AUGMENTIN ES suspension contains aspartame, which is a source of phenylalanine.&nbsp; This is important if your child has a condition called phenylketonuria (PKU), and you must tell your doctor if they have this condition.</p><p><strong>&nbsp;</strong></p><p><strong>How to prepare Augmentin suspension:</strong></p><p>At time of dispensing, the dry powder should be reconstituted to form an oral suspension, as detailed below:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Check cap seal is intact before use.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Invert and shake bottle to loosen powder.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Add volume of water (indicated below). Invert and shake well.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Alternatively, fill the bottle with water to just below the mark on bottle label.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Invert and shake well, then top up with water to the mark. Invert and shake again.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allow to stand for 5 minutes to ensure full dispersion.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shake well before giving each dose.</p><p>&nbsp;</p><p><em>Augmentin ES suspension</em></p><ul><li><strong>Orange flavour</strong></li></ul><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Bottle Size (ml)</strong></p></td><td style="vertical-align:top"><p>5</p></td><td style="vertical-align:top"><p>50</p></td><td style="vertical-align:top"><p>75</p></td><td style="vertical-align:top"><p>100</p></td><td style="vertical-align:top"><p>150</p></td><td style="vertical-align:top"><p>200</p></td></tr><tr><td style="vertical-align:top"><p><strong>Amount of Water Required for Suspension (ml)</strong></p></td><td style="vertical-align:top"><p>4.5</p></td><td style="vertical-align:top"><p>45</p></td><td style="vertical-align:top"><p>65</p></td><td style="vertical-align:top"><p>90</p></td><td style="vertical-align:top"><p>130</p></td><td style="vertical-align:top"><p>180</p></td></tr></tbody></table><p>&nbsp;</p><ul><li><strong>Strawberry cream flavour</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:83%"><tbody><tr><td style="vertical-align:top"><p><strong>Bottle Size (ml)</strong></p></td><td style="vertical-align:top"><p>50</p></td><td style="vertical-align:top"><p>75</p></td><td style="vertical-align:top"><p>100</p></td><td style="vertical-align:top"><p>150</p></td></tr><tr><td style="vertical-align:top"><p><strong>Amount of Water Required for Suspension (ml)</strong></p></td><td style="vertical-align:top"><p>50</p></td><td style="vertical-align:top"><p>70</p></td><td style="vertical-align:top"><p>90</p></td><td style="vertical-align:top"><p>135</p></td></tr></tbody></table><p>&nbsp;</p><p>When reconstituted in water at time of use, yields an off-white suspension.</p><p>Not all packs are available in all countries.</p><p>&nbsp;</p><p>Augmentin is a registered trademark of the GlaxoSmithKline group of companies.</p><p>&copy; 2024 GlaxoSmithKline, all rights reserved</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Augmentin ES suspension looks like and contents of the pack

§  Orange flavour

Off-white powder with a characteristic orange odour filled into glass bottles with polypropylene caps.

§  Strawberry cream flavour

Off-white powder with a characteristic strawberry odour filled into glass bottles with aluminium caps with a PVC liner.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p><strong>Manufacturing:</strong></p><p>Glaxo Wellcome Production* Mayenne, France.</p><p><strong>Packing:</strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, Kingdom of Saudi Arabia.</p><p><strong>Marketing Authorisation Holder </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, Kingdom of Saudi Arabia.</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia.</p><p>*member of the GlaxoSmithKline group of companies.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O Box 55850, Jeddah 21544, Kingdom of Saudi Arabia.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:roundrect
 id="AutoShape_x0020_16" o:spid="_x0000_s1026" style='position:absolute;
 margin-left:10.3pt;margin-top:248.2pt;width:481.9pt;height:183.55pt;z-index:251657728;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:margin;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page;v-text-anchor:top' arcsize="10923f" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal style='margin-bottom:0in'><b><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black'>THIS IS A MEDICAMENT</span></b><span
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0in;line-height:normal;mso-layout-grid-align:
    none;text-autospace:none'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>- Medicament is a product which affects your health, and its
    consumption contrary to <o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0in;line-height:normal;mso-layout-grid-align:
    none;text-autospace:none'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'><span style='mso-spacerun:yes'>   </span>instructions is
    dangerous for you.<o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0in;line-height:normal;mso-layout-grid-align:
    none;text-autospace:none'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>- Follow strictly the doctor’s prescription, the method of use
    and the instructions of the<span style='mso-spacerun:yes'>   </span><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0in;line-height:normal;mso-layout-grid-align:
    none;text-autospace:none'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'><span style='mso-spacerun:yes'>   </span>pharmacist who sold
    the medicament.<o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0in;line-height:normal;mso-layout-grid-align:
    none;text-autospace:none'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>- The doctor and the pharmacist are experts in medicine, its
    benefits and risks.<o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0in;line-height:normal;mso-layout-grid-align:
    none;text-autospace:none'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>- Do not by yourself interrupt the period of treatment
    prescribed for you.<o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0in;line-height:normal;mso-layout-grid-align:
    none;text-autospace:none'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>- Do not repeat the same prescription without consulting your
    doctor.<o:p></o:p></span></p>
    <p class=MsoNormal><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>- Keep all medicine out of reach of children<o:p></o:p></span></p>
    <p class=MsoNormal align=right style='margin-bottom:0in;margin-bottom:10.0pt;
    mso-margin-bottom-alt:10.0pt;mso-margin-top-alt:0in;mso-add-space:auto;
    text-align:right'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>Council of Arab Health Ministers<o:p></o:p></span></p>
    <p class=MsoNormal align=right style='margin-bottom:0in;margin-bottom:0in;
    margin-top:0in;mso-margin-bottom-alt:10.0pt;mso-margin-top-alt:0in;
    mso-add-space:auto;text-align:right'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>Union of Arab Pharmacists<o:p></o:p></span></p>
    <p class=MsoNormal><o:p>&nbsp;</o:p></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><v:roundrect id="AutoShape_x0020_25" o:spid="_x0000_s1027"
 style='position:absolute;margin-left:13.5pt;margin-top:-36pt;width:481.9pt;
 height:233pt;z-index:251659776;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' arcsize="10923f"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokecolor="black [3213]" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal style='margin-bottom:0in;mso-layout-grid-align:none;
    text-autospace:none'><b><span style='font-size:13.0pt;line-height:115%;
    font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>To report
    any side effect(s):<o:p></o:p></span></b></p>
    <p class=MsoNormal style='margin-bottom:0in;mso-layout-grid-align:none;
    text-autospace:none'><b><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'><o:p>&nbsp;</o:p></span></b></p>
    <p class=MsoNormal style='margin-bottom:0in;mso-layout-grid-align:none;
    text-autospace:none'><b><i><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>Kingdom of Saudi Arabia<o:p></o:p></span></i></b></p>
    <p class=MsoNormal style='margin-bottom:0in;mso-layout-grid-align:none;
    text-autospace:none'><b><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>-National Pharmacovigilance centre (NPC)<o:p></o:p></span></b></p>
    <ul style='margin-top:0in' type=disc>
     <li class=MsoNormal style='margin-bottom:0in;mso-list:l0 level1 lfo1'><span
         style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
         mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>Reporting
         Hotline:19999<o:p></o:p></span></li>
    </ul>
    <p class=MsoListParagraph style='margin-bottom:0in;text-indent:-.25in;
    line-height:normal;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    lang=FR style='font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;mso-ansi-language:FR'><span style='mso-list:
    Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span lang=FR
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    FR'>E-mail : </span><a href="mailto:npc.drug@sfda.gov.sa"><span
    style='color:windowtext;text-decoration:none;text-underline:none'>npc.drug@sfda.gov.sa</span></a><span
    lang=FR style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
    mso-ansi-language:FR'><o:p></o:p></span></p>
    <p class=MsoListParagraph style='margin-bottom:0in;text-indent:-.25in;
    line-height:normal;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    lang=FR style='font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;mso-ansi-language:FR'><span style='mso-list:
    Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span lang=FR
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    FR'>Website: </span><a href="https://ade.sfda.gov.sa"><span lang=FR
    style='color:windowtext;mso-ansi-language:FR;text-decoration:none;
    text-underline:none'>https://ade.sfda.gov.sa</span></a><span lang=FR
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    FR'> <o:p></o:p></span></p>
    <p class=MsoNormal style='margin-bottom:0in'><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'>-<b>GSK - Head Office, Jeddah<o:p></o:p></b></span></p>
    <ul style='margin-top:0in' type=disc>
     <li class=MsoNormal style='margin-bottom:0in;mso-list:l2 level1 lfo2'><a
         href="Tel:00966(02)6536666"><span style='font-family:"Times New Roman",serif;
         mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
         mso-bidi-theme-font:major-bidi;color:windowtext;text-decoration:none;
         text-underline:none'>Tel:<span style='mso-spacerun:yes'>  </span></span></a><span
         style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
         mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
         style='mso-spacerun:yes'> </span>+966-12-6536666<o:p></o:p></span></li>
    </ul>
    <p class=MsoListParagraph style='margin-bottom:0in;text-indent:-.25in;
    mso-list:l2 level1 lfo2'><![if !supportLists]><span style='font-family:
    Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
    style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi'>Mobile: +966-56-904-9882<o:p></o:p></span></p>
    <p class=MsoListParagraph style='margin-bottom:0in;text-indent:-.25in;
    line-height:normal;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    lang=FR style='font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;mso-ansi-language:FR'><span style='mso-list:
    Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span lang=FR
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    FR'>Email: </span><a href="mailto:saudi.safety@gsk.com"><span lang=FR
    style='color:windowtext;mso-ansi-language:FR;text-decoration:none;
    text-underline:none'>saudi.safety@gsk.com</span></a><span lang=FR
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    FR'> <o:p></o:p></span></p>
    <p class=MsoListParagraph style='margin-bottom:0in;text-indent:-.25in;
    line-height:normal;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    lang=FR style='font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;mso-ansi-language:FR'><span style='mso-list:
    Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span lang=FR
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    FR'>Website: </span><a href="https://gskpro.com/en-sa/"><span lang=FR
    style='color:windowtext;mso-ansi-language:FR;text-decoration:none;
    text-underline:none'>https://gskpro.com/en-sa/</span></a><span lang=FR
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    FR'> <o:p></o:p></span></p>
    <ul style='margin-top:0in' type=disc>
     <li class=MsoNormal style='margin-bottom:0in;mso-list:l2 level1 lfo2'><span
         style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
         mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>P.O
         Box 55850, Jeddah 21544, Kingdom of Saudi Arabia.<o:p></o:p></span></li>
    </ul>
    <p class=MsoNormal><o:p>&nbsp;</o:p></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td colspan="2" style="vertical-align:top"><img width="649" height="317" alt="Rectangle: Rounded Corners: To report any side effect(s):

Kingdom of Saudi Arabia
-National Pharmacovigilance centre (NPC)
•	Reporting Hotline:19999
•	E-mail : npc.drug@sfda.gov.sa
•	Website: https://ade.sfda.gov.sa 
-GSK - Head Office, Jeddah
•	Tel:   +966-12-6536666
•	Mobile: +966-56-904-9882
•	Email: saudi.safety@gsk.com 
•	Website: https://gskpro.com/en-sa/ 
•	P.O Box 55850, Jeddah 21544, Kingdom of Saudi Arabia.

" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /></td></tr><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td colspan="2" style="vertical-align:top"><img width="649" height="251" alt="Rectangle: Rounded Corners: THIS IS A MEDICAMENT
- Medicament is a product which affects your health, and its consumption contrary to 
   instructions is dangerous for you.
- Follow strictly the doctor’s prescription, the method of use and the instructions of the   
   pharmacist who sold the medicament.
- The doctor and the pharmacist are experts in medicine, its benefits and risks.
- Do not by yourself interrupt the period of treatment prescribed for you.
- Do not repeat the same prescription without consulting your doctor.
- Keep all medicine out of reach of children
Council of Arab Health Ministers
Union of Arab Pharmacists

" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" /></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version Number:  GDS29
Version Date: 07 September 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">أوجمنتين إي إس هو مضاد حيوي يحتوي على إثنين من المكونات الفعالة. واحد منهما هو پـنيسيللين يسمى أموكسيسيللين (على هيئة أموكسيسيللين ترايهيدرات) والآخر هو حمض الكلاﭬيولانيك (على هيئة بوتاسيوم كلاﭬيولانيت).<br />&nbsp;</p><p dir="RTL">يوصف أوجمنتين إي إس عادة للأطفال من عمر 3 أشهر فأكبر.<br />يستخدم أوجمنتين إي إس لعلاج الأطفال الذين يعانون من الإلتهابات التي تسببها البكتيريا.</p><p dir="RTL"><em>&nbsp;</em></p><p>اسأل طبيبك أو الصيدلي إذا أردت أي استفسارات أخرى عن هذه الاستعمالات</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تُعطي</strong><strong> </strong><strong>معلق أوجمنتين إي إس إذا كان:</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفلك مصاباً بحساسية من الأموكسيسيللين أو المضادات الحيوية من فئة البيتا لاكتام (مثل الـﭙـنيسيللين والسيفالوسـﭙـورين) أو أي من المكونات الأخرى من أوجمنتين إي إس. إذا كان لديهم رد فعل تحسسي (مثل الطفح الجلدي) عند تناول المضادات الحيوية، يجب عليك التحدث مع طبيبك قبل أن تعطي أوجمنتين إي إس.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفلك يعاني في أي وقت مضى من اليرقان (إصفرار الجلد و/أو العينين) أو أمراض الكبد عند تناول أوجمنتين إي إس.</p><p dir="RTL"><br /><strong>يجب مراعاة العناية الخاصة والحصول على المشورة من طبيبك إذا كان:</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يظهر على طفلك ردود الفعل التحسسية الشديدة مثل طفح جلدي أو قيء متكرر خلال ساعة إلى 4 ساعات من تناول أوجمنتين إي إس.&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عند تناول أوجمنتين إي إس. لا تعطي المزيد من المعلق وأخبر الطبيب فوراً.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفلك يعاني الحمى الغدية (كثرة الوحيدات) وتم وصف أوجمنتين إي إس لهم. يرجى إخبار الطبيب قبل إعطاء الدواء.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفلك لديه مشاكل في الكلى أو الكبد. قد تحتاج إلى تخفيض الجرعة أو قد تحتاج إلى أن تعطي أدوية أخرى.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفلك يعاني من حالة تدعى وجود الفينيل كيتون في البول (PKU). وذلك لأن أوجمنتين إي إس يحتوي على الأسپارتام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;&nbsp; </strong></p><p dir="RTL"><strong>تناول أدوية أخرى مع هذا الدواء، أو مستحضرات عشبية أو مدعمات غذائية</strong></p><p dir="RTL">فضلاً أخبر طبيبك أو الصيدلي إذا تعطي أو أعطيت طفلك أدوية أخرى مؤخراً. ويشمل هذا الأدوية التي تشتريها بدون وصفة طبية والأدوية العشبية. يرجع هذا لأن أوجمنتين ، قد يؤثر على طريقة عمل بعض الأدوية. وأيضاً بعض الأدوية الأخرى يمكن أن تؤثر في طريقة عمل أوجمنتين.</p><p dir="RTL">على وجه الخصوص، يجب أن يعرف الطبيبك ما إذا كان طفلك يتناول أي من الأدوية الآتية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألوﭘيورينول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﭙـروبنيسيد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات تخثر الدم (تستخدم لتفادي جلطات الدم) كالوارفارين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موفيتيل المايكوفينولات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميثوتريكسات (يستخدم لعلاج بعض الحالات مثل: السرطان والصدفية الشديدة).&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تكن متأكداً إذا كان أى مما أعلاه ينطبق على طفلك، فتحدث مع طبيبك أو الصيدلي قبل إعطاء معلق أوجمنتين إي إس.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL"><strong><em>معلق أوجمنتين معد للأطفال. التعليمات التالية عامة لجميع أشكال أوجمنتين:</em></strong></p><p dir="RTL">كشأن جميع الأدوية، لاتستخدمي أوجمنتين إذا كُنتِ حامل، خاصة في الثلاثة شهور الأولى، إلا إذا اعتُبره الطبيب ضرورياً.</p><p dir="RTL">تحدثي مع طبيبك أوالصيدلي قبل تناول أوجمنتين إذا كُنت حاملا أو تخططين للحمل.</p><p dir="RTL">لا مانع من تناول أوجمنتين أثناء الإرضاع باستثناء خطر نشوء حساسية. يجب استشارة الطبيب قبل تناول أي دواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التأثيرات</strong><strong> </strong><strong>على</strong><strong> </strong><strong>القدرة على القيادة</strong><strong> </strong><strong>واستخدام</strong><strong> </strong><strong>الآلات</strong></p><p dir="RTL">لم يرد ذكر أية تأثيرات لأوجمنتين على القدرة على قيادة السيارات أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب اتباع نصيحة الطبيب وتستخدم هذا الدواء وفقاً للتعليمات. الطبيب سوف يقرر كمية الدواء التي تحتاج إلى إعطائها كل يوم، وعدد الأيام لإعطاء الدواء.<br />عند وجود أي شيء لا تفهمه من فضلك اسأل طبيبك أو الصيدلي.<br />من الأفضل أن تعطي أوجمنتين إي إس في نفس وقت الوجبة، ولكن أوجمنتين إي إس يزاول مفعوله إذا تم تناوله من دون طعام.<br />توجد تعليمات حول كيفية تحضير معلق وجمنتين إي إس&nbsp; في نهاية هذه النشرة.</p><p dir="RTL">يرجى رج العبوة جيداً قبل تناول كل جرعة.</p><p dir="RTL">يمكن تزويد العبوة بجهاز الجرعات، والذي يمكنك استخدامه لقياس الجرعة بدقة.</p><p dir="RTL">تأكد من ابتلاع الجرعة كاملة في كل مرة.<br />إذا كنت تعطي أوجمنتين إي إس لطفل عمره يصل إلى سنتين، يمكن أن تخفف الجرعة إلى نصف التركيز بإضافة الماء مباشرة قبل أن تعطيها. لا تخزن الدواء المخفف.<br /><br /><strong>بمجرد أن بدأت إعطاء أوجمنتين إي إس</strong><br />يجب إعطاء الدواء حتى تمام مدة العلاج كاملة. لا تتوقف عندما يشعر طفلك بتحسن.<br /><br /><strong>إذا تناول طفلك أوجمنتين إي إس أكثر مما ينبغي:</strong><br />أعطه كمية وفيرة من الماء ليشربه واتصل بالطبيب. أعرض للطبيب عبوة أوجمنتين إي إس.<br /><br /><strong>إذا نسيت إعطاء جرعة من أوجمنتين إي إس:</strong><br />يجب إعطاء الجرعة في أقرب وقت تتذكرها فيه، ثم واصل العلاج على النحو السابق، يجب مراعاة عدم إعطاء جرعتين متتاليتين من الدواء في غضون ساعة واحدة.</p><p dir="RTL">&nbsp;</p><p>إذا كانت لديك أية أسئلة أخرى عن استعمال هذا المستحضر، اسأل الطبيب أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يمكن أن يسبب أوجمنتين إي إس آثارًا جانبية مثل جميع الأدوية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب الحذر من هذه الأعراض الهامة</p><p dir="RTL">&nbsp;</p><p dir="RTL">ردود الفعل التحسسية الشديدة</p><p dir="RTL">&nbsp;</p><p dir="RTL">هذه الأعراض نادرة جدًا عند الأشخاص الذين يتناولون أوجمنتين إي إس . تشمل العلامات ما يلي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي شديد، ومثير للحكة (شرى).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية، الذي قد يكون مرئيًا على شكل بقع حمراء أو أرجوانية بارزة على الجلد، ولكن يمكن أن تؤثر على أجزاء أخرى من الجسم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى وآلام المفاصل وتورم الغدد الموجودة في الرقبة أو الإبط أو الفخذ.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ في الوجه أو الفم في بعض الأحيان (وذمة وعائية)، مما قد يسبب صعوبة في البلع أو التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف شديد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر يمكن أن يكون علامة على رد فعل تحسسي خطير محتمل يسمى متلازمة كونس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء المتكرر (بعد ساعة إلى 4 ساعات من تناول أوجمنتين إي إس)، آلام في المعدة، نعاس غير طبيعي، إسهال، وانخفاض ضغط الدم؛ والتي يمكن أن تكون علامة على رد فعل تحسسي خطير يسمى متلازمة التهاب الأمعاء والقولون الناجم عن الأدوية.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احصل على المساعدة الطبية على الفور إذا ظهرت على طفلك أي من هذه الأعراض. يجب التوقف عن تناول أوجمنتين أي سي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; <strong>ردود الفعل الجلدية الخطيرة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">هذه نادرة عند الأشخاص الذين يتناولون أوجمنتين إي إس . تشمل العلامات ما يلي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي، الذي يُسبب تبثر، ويبدو وكأنه نفاخات صغيرة (بقع داكنة مركزية محاطة بمنطقة شاحبة، مع حلقة داكنة حول الحافة -حمامي متعددة الأشكال).</p><p dir="RTL">&nbsp;</p><p dir="RTL">هذه نادرة عند الأشخاص الذين يتناولون أوجمنتين إي إس . تشمل العلامات ما يلي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي واسع الانتشار مع ظهور بثور وتقشير الجلد، خاصة حول الفم والأنف والعينين والأعضاء التناسلية (متلازمة ستيفنز جونسون)، وشكل أكثر حدة يسبب بثور وتقشر الجلد على جزء كبير من سطح الجسم (انحلال البشرة السمي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أحمر ومنتشر مع ظهور بثور صغيرة تحتوي على صديد (البثار الطفحي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أحمر، ومثير للحكة، ويُسبب قشور مع ظهور بثور ونتوءات تحت الجلد (التهاب الجلد التقشري الفقاعي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض تُشبه الإنفلونزا مع طفح جلدي، وحمى، وتضخم في الغدد، ونتائج غير طبيعية لفحص الدم (تشمل خلايا الدم البيضاء (فرط الحمضات) وإنزيمات الكبد) (تفاعل الدواء مع فرط الحمضات والأعراض الجهازية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يظهر عادة طفح جلدي أحمر يظهر عادة على كلتا الأرداف كلتيهما، والجزء العلوي الداخلى من الفخذين، وتحت الإبطين، والرقبة ( الطفح الجلدي المتداخل وبين الثنايا المتماثل والمتعلق بالدواء (SDRIFE)).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احصل على المساعدة الطبية على الفور؛ إذا ظهرت على طفلك أي من هذه الأعراض. يجب التوقف عن تناول أوجمنتين إي إس .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>مشاكل الكبد الخطيرة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالات نادرة، يمكن أن تسبب الأدوية مثل أوجمنتين إي إس مشاكل في الكبد، مما يؤدي إلى اصفرار الجلد أو بياض العينين أو كلاهما.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخبر طبيبك المعالج في أسرع وقت ممكن؛ إذا ظهرت على طفلك أي من هذه الأعراض.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الإسهال الشديد (التهاب القولون الغشائي الكاذب)</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالات نادرة، يمكن للأدوية مثل أوجمنتين إي إس أن تسبب التهاب القولون (الأمعاء الغليظة)، مما يسبب الإسهال، وعادة مع وجود دم ومخاط، بالإضافة إلى ألم المعدة والحمى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخبر طبيبك المعالج في أسرع وقت ممكن؛ إذا ظهرت على طفلك أي من هذه الأعراض.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية الشائعة</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تظهر على ما يصل إلى 1 من كل 10 أشخاص:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; القلاع (عدوى فطرية تسببها المبيضات في المهبل أو الفم أو طيات الجلد).</p><p dir="RTL">&bull; جائش النفس (الغثيان).</p><p dir="RTL">&bull; القيء.</p><p dir="RTL">&bull; الإسهال .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الآثار الجانبية غير الشائعة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تظهر على ما يصل إلى 1 من كل 100 شخص:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; دوار.</p><p dir="RTL">&bull; صداع الرأس.</p><p dir="RTL">&bull; عسر الهضم.</p><p dir="RTL">&bull; الطفح الجلدي.</p><p dir="RTL">&bull; الحكة.</p><p dir="RTL">&bull; طفح جلدي شديد، ومثير للحكة (شرى).</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية غير الشائعة؛ التي يمكن أن تظهر في فحوصات الدم:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; زيادة في بعض المواد (الإنزيمات) التي ينتجها الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية النادرة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تظهر على ما يصل إلى 1 من كل 1000 شخص:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي، الذي يُسبب تبثر، ويبدو وكأنه نفاخات صغيرة (بقع داكنة مركزية محاطة بمنطقة شاحبة، مع حلقة داكنة حول الحافة -حمامي متعددة الأشكال) (انظر &quot;ردود الفعل الجلدية الخطيرة&quot; المذكورة سابقًا في القسم 4).</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية النادرة التي قد تظهر في اختبارات الدم هي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدم البيضاء (قلة الكريات البيض، بما في ذلك قلة العدلات).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد الخلايا التي تساعد الدم على التجلط (قلة الصفيحات).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية النادرة جدًا</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تظهر على ما يصل إلى 1 من كل 10,000 شخص:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود الفعل التحسسية الشديدة (انظر أيضًا &quot;ردود الفعل التحسسية الشديدة&quot; المذكورة سابقًا في القسم 4)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود الفعل جلدية الخطيرة (انظر أيضًا &quot;ردود الفعل الجلدية الخطيرة&quot; المذكورة سابقًا في القسم 4)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد (انظر أيضًا &quot;مشاكل الكبد الخطيرة&quot; المذكورة سابقًا في القسم 4)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار بياض العين أو الجلد (اليرقان) (انظر أيضًا &quot;مشاكل الكبد الخطيرة&quot; المذكورة سابقًا في القسم 4)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأمعاء الغليظة (انظر أيضًا &quot;الإسهال الشديد&quot; المذكورة سابقًا في القسم 4)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكلية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في الوقت الذي يستغرقه الدم للتجلط.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النشاط غير المعتاد (فرط النشاط).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اللسان الأسود الذي يبدو مشعرًا</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الغشاء الواقي المحيط بالدماغ (التهاب السحايا العقيم).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بقع الأسنان التي يمكن تنظيفها عادة بالفرشاة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مع ظهور بثور مرتبة في شكل دائرة وقشور في المركز أو كعقد من اللؤلؤ (داء الجلوبولين المناعي أ الخطي).</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية النادرة جدًا التي قد تظهر في اختبارات الدم أو البول هي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض شديد في عدد خلايا الدم البيضاء (ندرة المحببات).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تلف خلايا الدم الحمراء بسرعة كبيرة (فقر الدم الانحلالي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بلورات في البول.</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخبر طبيبك المعالج أو الصيدلي إذا أصبحت أي من الآثار الجانبية المذكورة شديدة أو مزعجة على طفلك، أو إذا لاحظت أي آثار جانبية غير مدرجة في هذه النشرة على طفلك.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>يحفظ بعيداً عن متناول ونظر الأطفال.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم معلق أوجمنتين إي إس بعد تاريخ إنتهاء الصلاحية المذكور على العبوة بعد كلمة &quot;Exp&quot;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب حفظ مسحوق أوجمنتين الجاف في حاويات مغلقة بإحكام في مكان جاف في درجة حرارة أقل من 30<sup>&deg;</sup> م في العبوة الأصلية للحفاظ عليه من الرطوبة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المعلق المخفف يجب حفظه في الثلاجة (2-8 <sup>&deg;</sup>م) واستعماله خلال 10 أيام، ولا يجوز تجميده.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أخبرك الطبيب بوقف إعطاء معلق أوجمنتين إي إس، فمن المهم أن تعيد ما تبقى من الدواء إلى الصيدلي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا ينبغي التخلص من الأدوية عن طريق مياة الصرف الصحي أو المخلفات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. سوف تساعد هذه التدابير في حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>على ماذا يحتوي معلق أوجمنتين إي إس 600</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المواد الفعالة:</p><p dir="RTL"><em>معلق أوجمنتين إي إس 600 </em>عند تحضيره يحتوي على 600 ملجم أموكسيسيللين (على هيئة أموكسيسيللين ترايهيدرات) و42.9 ملجم حمض الكلاﭬيولانيك (على هيئة بوتاسيوم كلاﭬيولانيت) لكل 5 مل. بنسبة (14 : 1).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مواد أخرى غير فعالة:</p><p dir="RTL"><em>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>تركيبة نكهة البرتقال</em></p><p dir="RTL">ثاني أكسيد السيليكون الغروي، نكهة البرتقال، نكهة الشراب الذهبي، صمغ الزانثان، أسپارتام، هيدروكسي پروپيل ميثيل سليولوز وثاني أوكسيد السيليكون.</p><p dir="RTL"><em>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>تركيبة نكهة الفراولة</em></p><p dir="RTL">ثاني أكسيد السيليكون الغروي، صوديم كاربوكسي ميثيل سليولوز-12، نكهة كريمة الفراولة، صمغ الزانثان، أسپارتام وثاني أوكسيد السيليكون.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ملطفات تتطلب تحذيرات خاصة</strong></p><p dir="RTL">معلق أوجمنتين إي إس يحتوي على الأسپارتام، الذي هو مصدر للفينيل ألانين. وهذا أمر مهم إذا كان طفلك لديه حالة تسمى وجود الفينيل كيتون في البول (PKU)، ويجب عليك إخبار الطبيب إذا كانت لديه هذا الحالة.</p><p dir="RTL"><strong>كيفية تحضير معلق أوجمنتين</strong></p><p dir="RTL">عند تركيب الدواء، يجب تخفيف المسحوق الجاف بالماء لتحضير معلق للإعطاء عن طريق الفم، على النحو المبيّن بالتفاصيل أدناه:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تأكد من سلامة الغطاء المحكم قبل الاستعمال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اقلب الزجاجة ورجها لتحريك المسحوق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أضف مقدار الماء (على النحو المبين أدناه). اقلب الزجاجة ورجها جيداً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن اتباع طريقة أخرى، املأ الزجاجة بالماء حتى أسفل العلامة الموجودة على ملصق الزجاجة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اقلب الزجاجة ورجها جيداً، ثم أكمل بالماء حتى العلامة. اقلب الزجاجة ورجها مرة أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اترك الزجاجة في وضع قائم لمدة 5 دقائق لضمان انتشار المسحوق بالكامل في الماء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رج الزجاجة جيداً قبل تناول كل جرعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>معلق أوجمنتين إي إس</em></p><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>تركيبة نكهة البرتقال</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>حجم القارورة (مل)</em></p></td><td><p dir="RTL"><em>5</em></p></td><td><p dir="RTL"><em>50</em></p></td><td><p dir="RTL"><em>75</em></p></td><td><p dir="RTL"><em>100</em></p></td><td><p dir="RTL"><em>150</em></p></td><td><p dir="RTL"><em>200</em></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><em>مقدار الماء المطلوب لتحضير المعلق (مل)</em></p></td><td><p dir="RTL"><em>4.5</em></p></td><td><p dir="RTL"><em>45</em></p></td><td><p dir="RTL"><em>65</em></p></td><td><p dir="RTL"><em>90</em></p></td><td><p dir="RTL"><em>130</em></p></td><td><p dir="RTL"><em>180</em></p></td></tr></tbody></table><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>تركيبة نكهة كريمة الفراولة</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>حجم القارورة (مل)</em></p></td><td><p dir="RTL"><em>50</em></p></td><td><p dir="RTL"><em>75</em></p></td><td><p dir="RTL"><em>100</em></p></td><td><p dir="RTL"><em>150</em></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><em>مقدار الماء المطلوب لتحضير المعلق (مل)</em></p></td><td><p dir="RTL"><em>50</em></p></td><td><p dir="RTL"><em>70</em></p></td><td><p dir="RTL"><em>90</em></p></td><td><p dir="RTL"><em>135</em></p></td></tr></tbody></table><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL">&nbsp;</p><p dir="RTL">عند تخفيف المسحوق بالماء وقت الاستخدام، يتكون معلق شبه أبيض.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو</strong> <strong>معلق أوجمنتين إي إس وما هي محتويات العبوة</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><em>نكهة البرتقال</em></p><p dir="RTL">مسحوق شبه أبيض برائحة برتقال مميزة معبأ داخل قوارير زجاجية مزودة بغطاء پولي پروبيلين.</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><em>نكهة كريمة الفراولة</em></p><p>مسحوق شبه أبيض برائحة فراولة مميزة معبأ داخل قوارير زجاجية مزودة بغطاء ألومنيوم له بطانة من مادة پي ڤي سي</p><p>&nbsp;</p><p dir="RTL">لاتتوافر جميع العبوات في كل البلدان.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أوجمنتين</strong> علامة تجارية مسجلة لمجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&copy; 2024 جلاكسو سميث كلاين، جميع الحقوق محفوظة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تصنيع</strong></p><p dir="RTL">جلاكسو ويلكام پـروداكشن*، مايين، فرنسا.</p><p dir="RTL"><strong>تعبئة</strong></p><p dir="RTL">جلاكسو العربية السعودية المحدودة* جدة، المملكة العربية السعودية.</p><p dir="RTL"><strong>الشركة المالكة لرخصة التسويق</strong></p><p dir="RTL">جلاكسو العربية السعودية المحدودة* جدة، المملكة العربية السعودية.</p><p dir="RTL">العنوان: صندوق بريد22617، جدة 21416، المملكة العربية السعودية.</p><p dir="RTL">*عضو في مجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإستفسار عن أي معلومات عن هذا المستحضر الدوائي، يرجى الإتصال بالأرقام التالية:</strong></p><p dir="RTL">جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666-12-966+</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال:9882-904-56-966+</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: gcc.medinfo@gsk.com</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب. 55850، جدة 21544، المملكة العربية السعودية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:roundrect id="AutoShape_x0020_34"
 o:spid="_x0000_s1027" style='position:absolute;left:0;text-align:left;
 margin-left:24.5pt;margin-top:6.25pt;width:481.9pt;height:195.3pt;z-index:251659776;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:margin;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page;v-text-anchor:top' arcsize="10923f" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokecolor="black [3213]" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><b><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
    AR-SA'>للإبلاغ عن أي آثار جانبية:</span></b><span dir=LTR style='font-size:
    11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi;mso-ansi-language:EN-GB;mso-fareast-language:
    EN-GB;mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><b><i><span lang=AR-SA style='font-size:11.0pt;
    font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'>المملكة العربية السعودية</span></i></b><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span dir=RTL></span><span dir=RTL></span><b><span
    lang=AR-SA style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi;color:black;mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span dir=RTL></span><span
    dir=RTL></span>- المركز الوطني للتيقظ والسلامة الدوائية (</span></b><b><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi;color:black;mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'>NPC</span></b><span
    dir=RTL></span><span dir=RTL></span><b><span lang=AR-SA style='font-size:
    11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'><span dir=RTL></span><span dir=RTL></span>)</span></b><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-right:63.35pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;mso-list:l0 level1 lfo1;tab-stops:list .5in;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;color:black;mso-font-kerning:12.0pt;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span
    style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
    AR-SA'>الاتصال بالرقم الموحد: 19999</span><span dir=LTR style='font-size:
    11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:12.0pt;
    mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-right:63.35pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;mso-list:l0 level1 lfo1;tab-stops:list .5in;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;color:black;mso-font-kerning:12.0pt;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span
    style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
    AR-SA'>البريد الإلكتروني: </span><span lang=EN-US><a
    href="mailto:npc.drug@sfda.gov.sa"><span lang=EN-GB dir=LTR
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
    AR-SA;text-decoration:none;text-underline:none'>npc.drug@sfda.gov.sa</span></a></span><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-right:63.35pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;mso-list:l0 level1 lfo1;tab-stops:list .5in;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;color:black;mso-font-kerning:12.0pt;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span
    style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
    AR-SA'>الموقع الإلكتروني: </span><span lang=EN-US><a
    href="https://ade.sfda.gov.sa/"><span lang=EN-GB dir=LTR style='font-size:
    11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:12.0pt;
    mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA;
    text-decoration:none;text-underline:none'>https://ade.sfda.gov.sa</span></a></span><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span dir=RTL></span><span dir=RTL></span><b><span
    lang=AR-SA style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi;color:black;mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span dir=RTL></span><span
    dir=RTL></span>- جلاكسو سميث كلاين – المكتب الرئيسي، جدة.</span></b><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-right:63.35pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;mso-list:l1 level1 lfo2;tab-stops:list .5in;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;mso-ansi-language:EN-GB;mso-fareast-language:
    EN-GB;mso-bidi-language:AR-SA'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'>هاتف: </span><span lang=AR-SA style='font-size:
    11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'>6536666</span><span dir=LTR></span><span dir=LTR></span><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi;color:black;mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span dir=LTR></span><span
    dir=LTR></span>-</span><span dir=RTL></span><span dir=RTL></span><span
    lang=AR-SA style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi;color:black;mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span dir=RTL></span><span
    dir=RTL></span>12</span><span dir=LTR></span><span dir=LTR></span><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi;color:black;mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span dir=LTR></span><span
    dir=LTR></span>-</span><span dir=RTL></span><span dir=RTL></span><span
    lang=AR-SA style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi;color:black;mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span dir=RTL></span><span
    dir=RTL></span>966+</span><span dir=LTR style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
    mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-right:63.35pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;mso-list:l1 level1 lfo2;tab-stops:list .5in;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;mso-ansi-language:EN-GB;mso-fareast-language:
    EN-GB;mso-bidi-language:AR-SA'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'>جوال: </span><span lang=AR-SA style='font-size:
    11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'>9882-904-56-966+</span><span dir=LTR
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-right:63.35pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;mso-list:l0 level1 lfo1;tab-stops:list .5in;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;color:black;mso-font-kerning:12.0pt;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span
    style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
    AR-SA'>البريد الإلكتروني: </span><span dir=LTR style='font-size:11.0pt;
    font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:12.0pt;
    mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'>s</span><span
    lang=EN-US dir=LTR><a href="mailto:Saudi.safety@gsk.com"><span lang=EN-GB
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
    AR-SA;text-decoration:none;text-underline:none'>audi.safety@gsk.com</span></a></span><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-right:63.35pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;mso-list:l0 level1 lfo1;tab-stops:list .5in;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;color:black;mso-font-kerning:12.0pt;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span
    style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
    AR-SA'>الموقع الإلكتروني: </span><span dir=LTR style='font-size:11.0pt;
    font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:12.0pt;
    mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'>https://gskpro.com/en-sa/
    <o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-right:63.35pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;mso-list:l1 level1 lfo2;tab-stops:list .5in;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol;mso-ansi-language:EN-GB;mso-fareast-language:
    EN-GB;mso-bidi-language:AR-SA'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;
    mso-bidi-language:AR-SA'>ص.ب. 55850، جدة 21544، المملكة العربية </span><span
    lang=AR-SA style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi;color:black;mso-font-kerning:12.0pt;mso-ansi-language:EN-GB;
    mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'>السعودية.</span><span
    dir=LTR></span><span dir=LTR></span><span lang=EN-US dir=LTR
    style='font-size:11.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
    major-bidi;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;color:black;mso-font-kerning:
    12.0pt;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><span dir=LTR></span><span
    dir=LTR></span><span style='mso-spacerun:yes'>  </span></span><span
    dir=LTR style='font-size:11.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
    EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><img width="649" height="267" alt="Rectangle: Rounded Corners: للإبلاغ عن أي آثار جانبية:
المملكة العربية السعودية
- المركز الوطني للتيقظ والسلامة الدوائية (NPC)
•	الاتصال بالرقم الموحد: 19999
•	البريد الإلكتروني: npc.drug@sfda.gov.sa
•	الموقع الإلكتروني: https://ade.sfda.gov.sa
- جلاكسو سميث كلاين – المكتب الرئيسي، جدة.
•	هاتف: 6536666-12-966+
•	جوال: 9882-904-56-966+
•	البريد الإلكتروني: saudi.safety@gsk.com
•	الموقع الإلكتروني: https://gskpro.com/en-sa/ 
•	ص.ب. 55850، جدة 21544، المملكة العربية السعودية.  
" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:roundrect id="AutoShape_x0020_18" o:spid="_x0000_s1026"
 style='position:absolute;left:0;text-align:left;margin-left:19.45pt;
 margin-top:8.9pt;width:485.95pt;height:164pt;z-index:251656704;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' arcsize="10923f"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><b><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'>إن هذا
    الدواء<o:p></o:p></span></b></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'>- الدواء
    مستحضر يؤثر على صحتك، واستهلاكه خلافا للتعليمات يعرضك للخطر.<o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'>- اتبع
    بدقة وصفة الطبيب، وطريقة الاستعمال المنصوص عليها، وتعليمات الصيدلانى الذى
    صرفها لك.<o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'>-
    فالطبيب والصيدلانى هما الخبيران بالدواء، وبنفعه وضرره.<o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'>- لا
    تقطع مدة العلاج المحددة لك من تلقاء نفسك.<o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'>- لا
    تكرر صرف الدواء بدون استشارة الطبيب.<o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'>- احتفظ
    بجميع الأدوية بعيداً عن متناول لأطفال.<span style='mso-spacerun:yes'>   
    </span><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'><span
    style='mso-tab-count:8'>                                                                                                </span>مجلس
    وزراء الصحة العرب <o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:11.0pt;font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
    major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-language:AR-SA'><span
    style='mso-tab-count:8'>                                                                                                </span></span><span
    lang=AR-SA style='font-size:11.0pt;font-family:"Traditional Arabic",serif;
    mso-bidi-language:AR-SA'><span style='mso-spacerun:yes'>   </span>اتحاد
    الصيادلة العرب<o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=EN-US dir=LTR style='font-size:9.0pt'><o:p>&nbsp;</o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><img width="655" height="225" alt="Rectangle: Rounded Corners: إن هذا الدواء
- الدواء مستحضر يؤثر على صحتك، واستهلاكه خلافا للتعليمات يعرضك للخطر.
- اتبع بدقة وصفة الطبيب، وطريقة الاستعمال المنصوص عليها، وتعليمات الصيدلانى الذى صرفها لك.
- فالطبيب والصيدلانى هما الخبيران بالدواء، وبنفعه وضرره.
- لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.
- لا تكرر صرف الدواء بدون استشارة الطبيب.
- احتفظ بجميع الأدوية بعيداً عن متناول لأطفال.    
								مجلس وزراء الصحة العرب 
								   اتحاد الصيادلة العرب

" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" /></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            نص رقم: GDS29
تاريخ الإصدار: 07 سبتمبر 2023


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Augmentin ES 600 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                When reconstituted each 5 mL contains 600 mg amoxicillin (as amoxicillin trihydrate) and 42.9 mg clavulanic acid (as potassium clavulanate), a 14:1 ratio.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Orange flavour
Off-white powder with a characteristic orange odour, which, when constituted in water at time of dispensing, yields an off-white suspension.
Strawberry cream flavour
AUGMENTIN ES is an off-white powder with a characteristic strawberry odour, which, when constituted in water at time of dispensing, yields an off-white to tan coloured, strawberry flavoured suspension.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>AUGMENTIN</em><em> ES</em> should be used in accordance with local official antibiotic-prescribing guidelines and local susceptibility data.</p><p><em>AUGMENTIN ES</em> is indicated for the treatment of paediatric patients with recurrent or persistent acute otitis media due to <em>Streptococcus pneumoniae </em>(penicillin minimum inhibitory concentration (MIC) less than or equal to 2 mg/ml), <em>Haemophilus influenzae<sup>#</sup></em> and <em>Moraxella catarrhalis<sup>#</sup></em>. Such patients are often characterised by antibiotic exposure for acute otitis media within the preceding 3 months, and are either aged &lt; 2 years or attend daycare.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Paediatric patients 3 months and older:</strong></p><p>&nbsp;</p><p>The recommended dose for <em>AUGMENTIN</em> <em>ES</em> is 90/6.4&nbsp;mg/kg/day in 2 divided doses at 12-hourly intervals for 10 days, (see chart below). There is no experience in paediatric patients weighing more than 40&nbsp;kg, or in adults. There are no clinical data on <em>AUGMENTIN</em> <em>ES<strong> </strong></em>in children under 3 months of age.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Body Weight (kg)</strong></p></td><td style="vertical-align:top"><p><strong>Volume of <em>AUGMENTIN</em> <em>ES</em></strong><em> </em><strong>providing 90/6.4 mg/kg/day</strong></p></td></tr><tr><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>3.0 mL twice daily</p></td></tr><tr><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>4.5 mL twice daily</p></td></tr><tr><td style="vertical-align:top"><p>16</p></td><td style="vertical-align:top"><p>6.0 mL twice daily</p></td></tr><tr><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>7.5 mL twice daily</p></td></tr><tr><td style="vertical-align:top"><p>24</p></td><td style="vertical-align:top"><p>9.0 mL twice daily</p></td></tr><tr><td style="vertical-align:top"><p>28</p></td><td style="vertical-align:top"><p>10.5 mL twice daily</p></td></tr><tr><td style="vertical-align:top"><p>32</p></td><td style="vertical-align:top"><p>12.0 mL twice daily</p></td></tr><tr><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>13.5 mL twice daily</p></td></tr></tbody></table><p><em>&nbsp;</em></p><p><em>AUGMENTIN ES</em> does not contain the same amount of<em> </em>clavulanate (as the potassium salt) as any of the other <em>AUGMENTIN</em> suspensions. <em>AUGMENTIN ES</em> contains 42.9 mg of clavulanate per 5 mL whereas <em>AUGMENTIN</em> 200&nbsp;mg/5 mL suspension contains 28.5 mg of clavulanate per 5 mL and the 400 mg/5 mL suspension contains 57 mg of clavulanate per 5 mL. Therefore, <em>AUGMENTIN</em> 200 mg/5 mL and 400 mg/5 mL suspensions<em> </em>should <em>not </em>be substituted for <em>AUGMENTIN ES,</em> as they are not interchangeable.</p><p><em>&nbsp;</em></p><p><em>Hepatic Impairment</em><!--[if supportFields]><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;font-family:
"Times New Roman",serif'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_18baad34-2ae0-4d07-b9c0-19cb737d6c61 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></i><![endif]--><em>&nbsp;</em><!--[if supportFields]><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;font-family:
"Times New Roman",serif'><span style='mso-element:field-end'></span></span></i><![endif]--></p><p><em>&nbsp;</em></p><p>Administer with caution; monitor hepatic function at regular intervals.</p><p>There are insufficient data on which to base a dosage recommendation.</p><p>&nbsp;</p><p><em>Renal Impairment</em></p><p>&nbsp;</p><p>There are no dosing recommendations for <em>AUGMENTIN ES</em> in patients with renal impairment.</p><p>&nbsp;</p><p><strong>Method of Administration</strong></p><p><strong><em>&nbsp;</em></strong></p><p>To minimise the potential for gastrointestinal intolerance, <em>AUGMENTIN ES</em> should be taken at the start of a meal.&nbsp; The absorption of <em>AUGMENTIN</em> is optimised when taken at the start of a meal.</p><p>&nbsp;</p><p>Treatment should not be extended beyond 14 days without review.</p><p>&nbsp;</p><p>Therapy can be started parenterally and continued with an oral preparation.</p><p>&nbsp;</p><p><strong>Note:</strong> SHAKE ORAL SUSPENSION WELL BEFORE USING<!--[if supportFields]><span
style='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN ES is contraindicated in patients with a history of hypersensitivity to beta-lactams, e.g. penicillins and cephalosporins.

AUGMENTIN ES is contraindicated in patients with a previous history of AUGMENTIN-associated jaundice/hepatic dysfunction.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with <em>AUGMENTIN ES,</em> careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens.</p><p>&nbsp;</p><p>Serious and occasionally fatal hypersensitivity (anaphylactoid) reactions have been reported in patients on penicillin therapy.&nbsp; These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity. Hypersensitivity reactions can also progress to Kounis syndrome, a serious allergic reaction that can result in myocardial infarction. Presenting symptoms of such reactions can include chest pain occurring in association with an allergic reaction to AUGMENTIN ES (see Undesirable effects). Drug-induced enterocolitis syndrome (DIES) has been reported mainly in children receiving AUGMENTIN ES (see Undesirable effects). DIES is an allergic reaction with the leading symptom of protracted vomiting (1-4 hours after medicinal product administration) in the absence of allergic skin or respiratory symptoms. Further symptoms could comprise abdominal pain, diarrhoea, hypotension or leucocytosis with neutrophilia. In severe cases, drug-induced enterocolitis syndrome can progress to shock. If an allergic reaction occurs, AUGMENTIN ES therapy should be discontinued and appropriate alternative therapy instituted.</p><p>&nbsp;</p><p>&nbsp;</p><p>Serious anaphylactoid reactions require immediate emergency treatment with adrenaline. Oxygen, intravenous steroids and airway management, including intubation may also be required.</p><p><strong>&nbsp;</strong></p><p><em>AUGMENTIN</em> <em>ES</em> should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.</p><p>&nbsp;</p><p>Prolonged use may also occasionally result in overgrowth of non-susceptible organisms.</p><p>&nbsp;</p><p>Pseudomembranous colitis has been reported with the use of antibiotics and may range in severity from mild to life-threatening. Therefore, it is important to consider its diagnosis in patients who develop diarrhoea during or after antibiotic use. If prolonged or significant diarrhoea occurs or the patient experiences abdominal cramps, treatment should be discontinued immediately and the patient investigated further.</p><p>&nbsp;</p><p>In general <em>AUGMENTIN ES</em> is well tolerated and possesses the characteristic low toxicity of the penicillin group of antibiotics. Periodic assessment of organ system functions, including renal, hepatic and haematopoietic function is advisable during prolonged therapy.</p><p>&nbsp;</p><p>Abnormal prolongation of prothrombin time (increased INR) has been reported rarely in patients receiving <em>AUGMENTIN</em> and oral anticoagulants.&nbsp; Appropriate monitoring should be undertaken when anticoagulants are prescribed concurrently.&nbsp; Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation.</p><p><em>&nbsp;</em></p><p><em>AUGMENTIN ES</em> should be used with caution in patients with evidence of hepatic dysfunction.</p><p>&nbsp;</p><p>In patients with renal impairment, dosage of <em>AUGMENTIN</em> should be adjusted according to the degree of impairment.&nbsp; No dosing recommendations can be made for <em>AUGMENTIN ES</em> in renally impaired patients (<em>Posology and mode of administration</em>).</p><p>In patients with reduced urine output, crystalluria (including acute renal injury) has been observed very rarely, predominantly with parenteral therapy. During the administration of high doses of amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular check of patency should be maintained (see Undesirable effects and Overdose).</p><p><em>&nbsp;</em></p><p><em>AUGMENTIN ES</em> contains aspartame (each 5 mL of suspension contains 7 mg of phenylalanine) and so should be used with caution in patients with phenylketonuria.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use with <em>AUGMENTIN</em> <em>ES</em> may result in increased and prolonged blood levels of amoxicillin but not of clavulanic acid.</p><p>&nbsp;</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of <em>AUGMENTIN</em> <em>ES</em> and allopurinol.</p><p>&nbsp;</p><p>In common with other antibiotics<em>, AUGMENTIN</em> may affect the gut flora, leading to lower oestrogen reabsorption and reduced efficacy of combined oral contraceptives.</p><p>In the literature there are rare cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin.&nbsp; If co-administration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of <em>AUGMENTIN</em>.</p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may not accurately represent changes in overall MPA exposure.</p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category B: Reproduction studies in animals (mice and rats at doses up to 10 times the human dose) with orally and parenterally administered <em>AUGMENTIN</em> have shown no teratogenic effects. In a single study in women with pre-term, premature rupture of the foetal membrane (pPROM), it was reported that prophylactic treatment with <em>AUGMENTIN</em> may be associated with an increased risk of necrotising enterocolitis in neonates. As with all medicines, use should be avoided in pregnancy, unless considered essential by the physician.</p><p><strong>Use in Lactation</strong><!--[if supportFields]><b style='mso-bidi-font-weight:
normal'><span style='font-size:11.0pt;font-family:"Times New Roman",serif'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_76b9a047-88d6-4a12-b66f-8a47d59ededd \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></b><![endif]--><strong>&nbsp;</strong><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;font-family:
"Times New Roman",serif'><span style='mso-element:field-end'></span></span></b><![endif]--></p><p><strong>&nbsp;</strong></p><p><em>AUGMENTIN</em> <em>ES</em> may be administered during the period of lactation. With the exception of the risk of sensitization, associated with the excretion of trace quantities in breast milk, there are no known detrimental effects for the breast-fed infant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse effects on the ability to operate machinery have not been observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Data from large clinical trials were used to determine the frequency of very common to rare undesirable effects. The frequencies assigned to all other undesirable effects (i.e., those occurring at &lt;1/10,000) were mainly determined using post-marketing data and refer to a reporting rate rather than a true frequency.</p><p>The following convention has been used for the classification of frequency:-</p><p>very common &ge; 1/10</p><p>common &ge;&nbsp;1/100 to &lt; 1/10</p><p>uncommon &ge; 1/1000 to &lt; 1/100</p><p>rare &ge; 1/10,000 to &lt; 1/1000</p><p>very rare &lt;1/10,000.&nbsp;</p><p><strong>Infections and infestations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>Common &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mucocutaneous candidiasis</p><p><strong>Blood and lymphatic system disorders </strong></p><p>Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible leucopenia (including neutropenia) and thrombocytopenia</p><p>Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible agranulocytosis and haemolytic anaemia. Prolongation of bleeding time and prothrombin time</p><p><strong>Immune system disorders </strong></p><p>Very Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Angioneurotic oedema, anaphylaxis (see<em> Special Warnings and Precautions</em>), serum sickness-like syndrome, hypersensitivity vasculitis. (see also <em>Skin and subcutaneous tissue disorders</em>).</p><p><strong>Nervous system disorders</strong></p><p>Uncommon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness, headache</p><p>Very Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible hyperactivity, aseptic meningitis, convulsions. Convulsions may occur in patients with impaired renal function or in those receiving high doses.</p><p><strong>Cardiac disorders</strong></p><p>Very Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kounis syndrome (see <em>Special warnings and precautions for use</em>).</p><p>Not known&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aseptic meningitis</p><p><strong>Gastrointestinal disorders</strong></p><p>Common &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Diarrhoea, nausea, vomiting</p><p>Nausea is more often associated with higher oral dosages. If gastrointestinal reactions are evident, they may be reduced by taking <em>AUGMENTIN </em>at the start of a meal.</p><p>&nbsp;</p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Indigestion</p><p>Very Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; Antibiotic-associated colitis (including pseudomembranous colitis and haemorrhagic colitis)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Black hairy tongue.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Superficial tooth discolouration has been reported very rarely in children. Good oral hygiene may help to prevent tooth discolouration as it can usually be removed by brushing.</p><p>Not known: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Drug-induced enterocolitis syndrome, (see Special warnings and precautions for use),Pancreatitis acute</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Hepatobiliary disorders</strong></p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A moderate rise in AST and/or ALT has been noted in patients treated with beta-lactam class antibiotics, but the significance of these findings is unknown</p><p>Very Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis and cholestatic jaundice. These events have been noted with other penicillins and cephalosporins.</p><p>&nbsp;</p><p>Hepatic events have been reported predominantly in males and elderly patients and may be associated with prolonged treatment. These events have been very rarely reported in children.</p><p>&nbsp;</p><p>Signs and symptoms usually occur during or shortly after treatment but in some cases may not become apparent until several weeks after treatment has ceased.&nbsp; These are usually reversible. Hepatic events may be severe and in extremely rare circumstances, deaths have been reported. These have almost always occurred in patients with serious underlying disease or taking concomitant medications known to have the potential for hepatic effects.</p><p><em>&nbsp;</em></p><p><strong>Skin and subcutaneous tissue disorders </strong></p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash, pruritus, urticaria</p><p>Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erythema multiforme</p><p>Very Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous exfoliative-dermatitis, acute generalised exanthemous pustulosis (AGEP),<strong> </strong>drug reaction with eosinophilia and systemic symptoms (DRESS) and symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) (baboon syndrome) (see<em> </em>also<em> Immune system disorders</em>).If any hypersensitivity dermatitis reaction occurs, treatment should be discontinued.</p><p>Not Known&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Linear IgA disease</p><p><strong>Renal and urinary disorders</strong></p><p>Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interstitial nephritis</p><p>Not known&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Crystalluria (including acute renal injury) (see Overdose).</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>To report any side effect(s):</strong></p><p><strong>&nbsp;</strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p>-<strong>National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><ul><li>Reporting Hotline:19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa</li></ul><p>-<strong>GSK - Head Office, Jeddah</strong></p><ul><li>Tel: +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: saudi.safety@gsk.com</li><li>Website: https://gskpro.com/en-sa/</li><li>P.O Box 55850, Jeddah 21544, Saudi Arabia.</li></ul><p>&nbsp;</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com &nbsp;&nbsp;&nbsp;</li><li>Website: https://gskpro.com/en-sa/</li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Gastrointestinal symptoms<strong> </strong>may be treated symptomatically, with attention to the water/electrolyte balance.</p><p>&nbsp;</p><p>Amoxicillin crystalluria, in some cases leading to renal failure, has been observed (see<em> Special warnings and precautions for use).</em></p><p>&nbsp;</p><p><em>AUGMENTIN ES</em> can be removed from the circulation by haemodialysis.</p><p>&nbsp;</p><p>A prospective study of 51 paediatric patients at a poison control centre suggested that overdosages of less than 250&nbsp;mg/kg of amoxicillin are not associated with significant clinical symptoms and do not require gastric emptying.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC Code<!--[if supportFields]><span style='mso-bidi-font-size:11.0pt;
font-family:"Times New Roman",serif'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_c06dee0d-ffca-43f1-864b-db07dad1f69b \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Anatomical Therapeutic Chemical (ATC) code: J01CR02.</p><p>Pharmacotherapeutic group: Combinations of penicillins, incl. beta-lactamase inhibitors.</p><p>Mechanism of Action</p><p>Amoxicillin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity against many gram-positive and gram-negative microorganisms. Amoxicillin is, however, susceptible to degradation by beta-lactamases and, therefore, the spectrum of activity of amoxicillin alone does not include organisms which produce these enzymes.</p><p>Clavulanic acid is a beta-lactam, structurally related to the penicillins, which possesses the ability to inactivate a wide range of beta-lactamase enzymes commonly found in microorganisms resistant to penicillins and cephalosporins. In particular, it has good activity against the clinically important plasmid mediated beta-lactamases frequently responsible for transferred drug resistance. It is generally less effective against chromosomally-mediated type 1 beta-lactamases.</p><p>The clavulanate component in <em>AUGMENTIN ES</em> protects amoxicillin from degradation by beta-lactamase enzymes and effectively extends the antibacterial spectrum of amoxicillin to include many bacteria normally resistant to amoxicillin and other penicillins and cephalosporins. Thus, <em>AUGMENTIN ES</em> possesses the distinctive properties of a broad-spectrum antibiotic and a beta-lactamase inhibitor.</p><p>&nbsp;</p><p>5.1.2 Pharmacodynamic Effects<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_5004709d-d49b-42c8-b7ed-02faf3e76377 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]-->In the list below, organisms are categorised according to their <em>in vitro</em> susceptibility to <em>AUGMENTIN</em>.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong><em>In vitro</em></strong><strong> susceptibility of micro-organisms to <em>AUGMENTIN</em></strong></p><p>&nbsp;</p><p>Where clinical efficacy of <em>AUGMENTIN</em> has been demonstrated in clinical trials this is indicated with an asterisk (*).</p><p>&nbsp;</p><p>Organisms that do not produce beta-lactamase are identified (with <sup>&dagger;</sup>).&nbsp; If an isolate is susceptible to amoxicillin, it can be considered susceptible to <em>AUGMENTIN</em>.</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Commonly susceptible species</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p><em>Bacillius anthracis</em></p><p><em>Enterococcus faecalis</em></p><p><em>Listeria monocytogenes</em></p><p><em>Nocardia asteroides</em></p><p><em>Streptococcus</em><em> pneumoniae*</em><sup>&dagger;</sup></p><p><em>Streptococcus pyogenes</em><em>*</em><sup>&dagger;</sup></p><p><em>Streptococcus agalactiae</em><em>*</em><sup>&dagger;</sup></p><p>Viridans group streptococcus<sup>&dagger;</sup></p><p><em>Streptococcus</em> spp. (other beta-haemolytic)<em> *</em><sup>&dagger;</sup></p><p><em>Staphylococcus aureus</em> (methicillin susceptible)*</p><p><em>Staphylococcus saprophyticus</em> (methicillin susceptible)</p><p>Coagulase negative staphylococcus (methicillin susceptible)</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Bordetella pertussis</em></p><p><em>Haemophilus influenzae*</em></p><p><em>Haemophilus parainfluenzae</em></p><p><em>Helicobacter pylori</em></p><p><em>Moraxella catarrhalis*</em></p><p><em>Neisseria gonorrhoeae</em></p><p><em>Pasteurella multocida</em></p><p><em>Vibrio cholerae</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Other:</u></p><p><em>Borrelia burgdorferi</em></p><p><em>Leptospira ictterohaemorrhagiae</em></p><p><em>Treponema pallidum</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram positive anaerobes:</u></p><p><em>Clostridium </em>spp.</p><p><em>Peptococcus niger</em></p><p><em>Peptostreptococcus magnus</em></p><p><em>Peptostreptococcus micros</em></p><p><em>Peptostreptococcus</em> spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative anaerobes:</u></p><p><em>Bacteroides fragilis</em></p><p><em>Bacteroides</em> spp.</p><p><em>Capnocytophaga</em> spp.</p><p><em>Eikenella corrodens </em></p><p><em>Fusobacterium</em><em> nucleatum</em></p><p><em>Fusobacterium</em> spp.</p><p><em>Porphyromonas</em> spp.</p><p><em>Prevotella</em> spp.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Species for which acquired resistance may be a problem</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Escherichia coli*</em></p><p><em>Klebsiella oxytoca</em></p><p><em>Klebsiella pneumoniae*</em></p><p><em>Klebsiella</em> spp.</p><p><em>Proteus mirabilis</em></p><p><em>Proteus vulgaris</em></p><p><em>Proteus</em> spp.</p><p><em>Salmonella</em> spp.</p><p><em>Shigella </em>spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p><em>Corynebacterium</em> spp.</p><p><em>Enterococcus faecium</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Inherently resistant organisms</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Acinetobacter</em> spp.</p><p><em>Citrobacter freundii</em></p><p><em>Enterobacter</em> spp.</p><p><em>Hafnia alvei</em></p><p><em>Legionella pneumophila</em></p><p><em>Morganella morganii</em></p><p><em>Providencia </em>spp.</p><p><em>Pseudomonas</em> spp.</p><p><em>Serratia</em> spp.</p><p><em>Stenotrophomas maltophilia</em></p><p><em>Yersinia enterolitica</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Others:</u></p><p><em>Chlamydia pneumoniae</em></p><p><em>Chlamydia psittaci</em></p><p><em>Chlamydia</em> spp.</p><p><em>Coxiella burnetti</em></p><p><em>Mycoplasma</em><em> </em>spp.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacokinetic parameters are given below for <em>AUGMENTIN ES</em> administered at 45 mg/kg every 12 hours to paediatric patients</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Formulation</strong></p></td><td style="vertical-align:top"><p><strong>C max</strong></p><p><strong>(mg/L)</strong></p></td><td style="vertical-align:top"><p><strong>T max</strong></p><p><strong>(hours)</strong></p></td><td style="vertical-align:top"><p><strong>AUC</strong></p><p><strong>(mg.h/L)</strong></p></td><td style="vertical-align:top"><p><strong>T &frac12;</strong></p><p><strong>(hours)</strong></p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><em>AUGMENTIN ES</em></p><p>600/42.9&nbsp;mg/5 mL</p><p>Dosed at</p><p>45&nbsp;mg/kg amoxicillin 12-hourly</p><p>&nbsp;</p></td><td colspan="4" style="vertical-align:top"><p><strong><em>Amoxicillin</em></strong></p></td></tr><tr><td style="vertical-align:top"><p>15.7</p></td><td style="vertical-align:top"><p>2.0</p></td><td style="vertical-align:top"><p>59.8</p></td><td style="vertical-align:top"><p>1.4</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><strong>Clavulanate</strong></p></td></tr><tr><td style="vertical-align:top"><p>1.7</p></td><td style="vertical-align:top"><p>1.1</p></td><td style="vertical-align:top"><p>4.0</p></td><td style="vertical-align:top"><p>1.1</p></td></tr></tbody></table><p>&nbsp;</p><p>The pharmacokinetics of the two components of <em>AUGMENTIN ES</em> are closely matched. Both clavulanate and amoxicillin have low levels of serum binding; about 70% remains free in the serum.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No further information of relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Orange flavour</p><p><strong>Powder for oral suspension:</strong> colloidal silicon dioxide, orange flavour, golden syrup flavour, xanthan gum, aspartame, hydroxypropylmethylcellulose and silicon dioxide.</p><p>Strawberry cream flavour</p><p>&nbsp;</p><p>AUGMENTIN ES powder for suspension contains colloidal silicon dioxide, sodium carboxymethylcellulose-12, strawberry cream flavour, xanthan gum, aspartame, and silicon dioxide.</p><p>For important information about some of these excipients (see <em>Special Warnings and Precautions</em>)<em>.</em></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The powder for oral suspension should be stored in a well sealed container, in a dry place at or below 30&deg;C. Reconstituted suspensions should be stored in a refrigerator (2-8&deg;C) and used within 10 days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>AUGMENTIN ES powder for oral suspension, is supplied in clear glass bottles containing dry powder for reconstitution. Bottles may be supplied with either an aluminium screw cap with a ring seal or a plastic child-resistant cap with a removable foil-backed seal on the bottle. Fill-lines are indicated on the bottle label. Bottles may be supplied with a plastic dosing device.</em></p><p><strong><em>Orange flavour</em></strong></p><p>The dry powder is filled into glass bottles with polypropylene caps.</p><p><strong><em>Strawberry cream flavour</em></strong></p><p>The dry powder is filled into glass bottles with aluminium caps with a PVC or Polyolefin<strong><em> </em></strong>liner.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For bottles with aluminum screw caps, check the cap seal is intact before using. Alternatively, for bottles with a plastic child-resistant cap, check the foil-backed bottle seal is intact before using.</p><p>At time of use, the dry powder should be reconstituted to form an oral suspension, as detailed below:</p><p>&nbsp;</p><p>&bull; Invert and shake bottle to loosen powder.</p><p>&bull; Add volume of water (indicated below). Invert and shake well.</p><p>&bull; Alternatively, fill the bottle with water to just below the mark on bottle label.</p><p>&nbsp; Invert and shake well, then top up with water to the mark. Invert and shake again.</p><p>&bull; Shake well before taking each dose.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong><em>AUGMENTIN</em></strong><strong> <em>ES</em></strong></p><p><strong>Orange flavour</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Bottle Size (ml)</strong></p></td><td style="vertical-align:top"><p><strong>Amount of Water Required for Suspension (ml)</strong></p></td></tr><tr><td style="vertical-align:top"><p>5</p></td><td style="vertical-align:top"><p>4.5</p></td></tr><tr><td style="vertical-align:top"><p>50</p></td><td style="vertical-align:top"><p>45</p></td></tr><tr><td style="vertical-align:top"><p>75</p></td><td style="vertical-align:top"><p>65</p></td></tr><tr><td style="vertical-align:top"><p>100</p></td><td style="vertical-align:top"><p>90</p></td></tr><tr><td style="vertical-align:top"><p>150</p></td><td style="vertical-align:top"><p>130</p></td></tr><tr><td style="vertical-align:top"><p>200</p></td><td style="vertical-align:top"><p>180</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Bottle Size (mL)</strong></p></td><td style="vertical-align:top"><p>Amount of Water Required for Suspension (mL)</p></td></tr><tr><td style="vertical-align:top"><p>50</p></td><td style="vertical-align:top"><p>50</p></td></tr><tr><td style="vertical-align:top"><p>75</p></td><td style="vertical-align:top"><p>70</p></td></tr><tr><td style="vertical-align:top"><p>100</p></td><td style="vertical-align:top"><p>90</p></td></tr><tr><td style="vertical-align:top"><p>150</p></td><td style="vertical-align:top"><p>135</p></td></tr></tbody></table><p>A dosing device may be supplied with the pack, which can be used to measure the dose accurately.</p><p>Discard unused suspension after 10 days.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements<strong><s> </s></strong>.Not all presentations are available in every country.</p><p><em>Augmentin</em> is registered trademarks of the GlaxoSmithKline group of companies</p><p>&copy; 2024 GlaxoSmithKline, all rights reserved.</p><p>&nbsp;</p><p>INSTRUCTIONS TO THE PATIENT</p><p>THIS IS A MEDICAMENT</p><p>Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you.</p><p>Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.</p><p>The Doctor and the Pharmacist are experts in medicine, its benefits and risks.</p><p>Do not by yourself interrupt the period of treatment prescribed for you.</p><p>Do not repeat the same prescription without consulting your doctor.</p><p>KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN</p><p>Council of Arab Health Ministers</p><p>Union of Arab Pharmacists</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufacturing:
Glaxo Wellcome Production* Mayenne, France
Packing:
Glaxo Saudi Arabia Ltd.* Jeddah, KSA


7.	Marketing Authorisation Holder 
Glaxo Saudi Arabia Ltd.* Jeddah, KSA
Address: P.O. Box 22617 Jeddah 21416 – Kingdom of Saudi Arabia
*member of the GlaxoSmithKline group of companies

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: GDS29/IPI15
Date of issue:  07 September 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>